Cutaneous B‐cell lymphomas: 2019 update on diagnosis, risk stratification, and management
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Hematology"
DOI: 10.1002/ajh.25224
Abstract: Approximately one‐fourth of cutaneous lymphomas are B‐cell derived and are generally classified into three distinct subgroups: primary cutaneous follicle center lymphoma (PCFCL), primary cutaneous marginal zone lymphoma (PCMZL), and primary cutaneous diffuse large B‐cell lymphoma,… read more here.
Keywords: cutaneous cell; lymphomas; lymphomas 2019; cell lymphomas ... See more keywords
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26760
Abstract: Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis Fungoides (MF) or Sézary Syndrome (SS). read more here.
Keywords: cell; 2023 update; lymphomas 2023; update diagnosis ... See more keywords
Double hit and double expressors in lymphoma: Definition and treatment
Sign Up to like & getrecommendations! Published in 2018 at "Cancer"
DOI: 10.1002/cncr.31646
Abstract: Emerging biologic subsets and new prognostic markers are significantly and adversely affecting curability after standard chemoimmunotherapy for aggressive B‐cell lymphomas. The identification of concurrent MYC and B‐cell CLL/lymphoma 2 (BCL2) deregulation, whether at a genomic… read more here.
Keywords: lymphoma; double hit; cell lymphomas; hit double ... See more keywords
Pitfalls and major issues in the histologic diagnosis of peripheral T‐cell lymphomas: results of the central review of 573 cases from the T‐Cell Project, an international, cooperative study
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2316
Abstract: Peripheral T‐cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are derived from post‐thymic lymphoid cells at different stages of differentiation with different morphological patterns, phenotypes and clinical presentations. PTCLs are highly diverse, reflecting… read more here.
Keywords: cell lymphomas; cell project; study; cell ... See more keywords
Treatment of aggressive B‐cell lymphomas
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2407
Abstract: The treatment of aggressive B‐cell lymphomas is in evolution, largely based on the recognition of major genetic and biologic subtypes harboring distinct pathogenetic lesions. In this review, we will consider current treatment options with the… read more here.
Keywords: aggressive cell; chop; treatment; cell lymphomas ... See more keywords
MOLECULAR CHARACTERIZATION OF EXTRANODAL NATURAL KILLER (NK)/T‐CELL LYMPHOMAS, NASAL TYPE FROM LATIN AMERICA
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2437_115
Abstract: clinical trial is still ongoing (ClinicalTrials.gov, NCT 2085655). Furthermore, promising response of single agent, chidamide, a new oral HDAC inhibitor, for the treatment of relapsed or refractory NK/ TCL without significant EBV‐reactivation was recently observed… read more here.
Keywords: molecular characterization; killer cell; characterization extranodal; cell lymphomas ... See more keywords
Rare mature B‐cell lymphomas in children and adolescents
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.2585
Abstract: Pediatric‐type follicular lymphoma (PTFL), pediatric nodal marginal zone lymphoma (pnMZL), and large B‐cell lymphoma (LBCL) with IRF4 rearrangement have been introduced into the current World Health Organization (WHO) classification. They account for 5% to 10%… read more here.
Keywords: lymphomas children; mature cell; cell lymphomas; children adolescents ... See more keywords
What we should know about natural killer/T‐cell lymphomas
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.2588
Abstract: Natural‐killer/T cell lymphoma (NKTCL) is the most common extranodal lymphoma with highly aggressive clinical outcome. System biology techniques provide novel insights into the pathogenesis, risk stratification, and clinical management in NKTCL. Comparative genomic hybridization analysis… read more here.
Keywords: killer cell; know natural; cell lymphomas; natural killer ... See more keywords
Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B‐cell lymphomas
Sign Up to like & getrecommendations! Published in 2021 at "Hematological Oncology"
DOI: 10.1002/hon.2871
Abstract: Bendamusutine plus rituximab (BR) regimen is one of the standard regimens for indolent B‐cell lymphomas, yet the possibility of reduction of cycles of BR therapy without compromising therapeutic effects is not still uncovered. We retrospectively… read more here.
Keywords: response; indolent cell; cell lymphomas; reduction cycles ... See more keywords
The “m6A writer” METTL3 and the “m6A reader” IGF2BP2 regulate cutaneous T‐cell lymphomas progression via CDKN2A
Sign Up to like & getrecommendations! Published in 2022 at "Hematological Oncology"
DOI: 10.1002/hon.3005
Abstract: It has been established that Cutaneous T‐Cell lymphomas (CTCL) are caused by the monoclonal proliferation of T lymphocytes in the skin. This heterogeneous group of diseases represents a significant source of distress to patients since… read more here.
Keywords: progression; ctcl; cell lymphomas; m6a ... See more keywords
Origin and Pathogenesis of B Cell Lymphomas.
Sign Up to like & getrecommendations! Published in 2019 at "Methods in molecular biology"
DOI: 10.1007/978-1-4939-9151-8_1
Abstract: Immunoglobulin (IG) gene remodeling by V(D)J recombination plays a central role in the generation of normal B cells, and somatic hypermutation and class switching of IG genes are key processes during antigen-driven B cell differentiation.… read more here.
Keywords: many cell; cell lymphomas; pathogenesis cell; development ... See more keywords